semaglutide qualifications What BMI Do You Need to Qualify for GLP-1? A weekly dose of semaglutide

The SELECT studies showed that SMG (Wegovy ) in addition to significant weight loss of -10% in the long term (208 weeks) in individuals with obesity or overweight without diabetes and with pre-existing cardiovascular disease [127] also reduces the risk of death from cardiovascular causes, non-fatal myocardial infarction, or non-fatal stroke by 20% [128], which was independent of baseline HbA1c or HbA1c change during the study [129]

Current Opinion in Microbiology

Stopping abruptly reverses these adaptations, sometimes creating a temporary metabolic mismatch where blood sugar regulation is less efficient than before treatment

Simply click the button to view a full set of contact details